(PharmaNewsWire.Com, October 04, 2017 ) Alopecia is the partial or complete loss of hair especially on the scalp either in patches on the entire head or over the entire body. Thinning hair is the most obvious symptom. The predisposing factors include allergies irritants toxins burns injuries and infections.
Report Highlights
Publisher's Pharmaceutical and Healthcare latest pipeline guide Alopecia-Pipeline Review H2 2017 provides comprehensive information on the therapeutics under development for Alopecia (Dermatology) complete with analysis by stage of development drug target mechanism of action (MoA) route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics its complete research and development history and latest news and press releases.
The Alopecia (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Alopecia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes the molecules developed by Companies in Pre-Registration Phase III Phase II Phase I IND/CTA Filed Preclinical and Discovery stages are 1 1 12 5 1 19 and 9 respectively. Similarly the Universities portfolio in Phase III and Discovery stages comprises 1 and 1 molecules respectively.
Alopecia (Dermatology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher's proprietary databases company/university websites clinical trial registries conferences SEC filings investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Note Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.
Number of Products under Development for Alopecia H2 2017 Number of Products under Development by Companies H2 2017 Number of Products under Development by Companies H2 2017 (Contd..1) H2 2017 Number of Products under Development by Universities/Institutes H2 2017 Products under Development by Companies H2 2017 Products under Development by Companies H2 2017 (Contd..1) H2 2017 Products under Development by Companies H2 2017 (Contd..2) H2 2017 Products under Development by Universities/Institutes H2 2017 Number of Products by Stage and Target H2 2017 Number of Products by Stage and Target H2 2017 (Contd..1) H2 2017 Number of Products by Stage and Mechanism of Action H2 2017 Number of Products by Stage and Mechanism of Action H2 2017 (Contd..1) H2 2017 Number of Products by Stage and Route of Administration H2 2017 Number of Products by Stage and Molecule Type H2 2017 Alopecia-Pipeline by Aclaris Therapeutics Inc H2 2017 Alopecia-Pipeline by Allergan Plc H2 2017 Alopecia-Pipeline by Almirall SA H2 2017 Alopecia-Pipeline by AndroScience Corp H2 2017 Alopecia-Pipeline by Berg LLC H2 2017 Alopecia-Pipeline by BiologicsMD Inc H2 2017 Alopecia-Pipeline by BirchBioMed Inc H2 2017 Alopecia-Pipeline by Brickell Biotech Inc H2 2017 Alopecia-Pipeline by Bristol-Myers Squibb Company H2 2017 Alopecia-Pipeline by Cassiopea SpA H2 2017 Alopecia-Pipeline by Daewoong Pharmaceutical Co Ltd H2 2017 Alopecia-Pipeline by Dong-A Socio Holdings Co Ltd H2 2017 Alopecia-Pipeline by Handok Inc H2 2017 Alopecia-Pipeline by Histogen Inc H2 2017 Alopecia-Pipeline by Hyundai Pharmaceutical Co Ltd H2 2017 Alopecia-Pipeline by Incyte Corp H2 2017 Alopecia-Pipeline by Kuhnil Pharmaceutical Co Ltd H2 2017 Alopecia-Pipeline by Lee's Pharmaceutical Holdings Ltd H2 2017 Alopecia-Pipeline by LEO Pharma A/S H2 2017 Alopecia-Pipeline by Medivir AB H2 2017 Alopecia-Pipeline by NovaLead Pharma Pvt Ltd H2 2017 Alopecia-Pipeline by Panacea Biotec Ltd H2 2017 Alopecia-Pipeline by Pfizer Inc H2 2017 Alopecia-Pipeline by Quark Pharmaceuticals Inc H2 2017 Alopecia-Pipeline by RXi Pharmaceuticals Corp H2 2017 Alopecia-Pipeline by Samumed LLC H2 2017 Alopecia-Pipeline by Switch Biotech LLC H2 2017 Alopecia-Pipeline by Taisho Pharmaceutical Holdings Co Ltd H2 2017 Alopecia-Pipeline by Tigo GmbH H2 2017 Alopecia-Pipeline by viDA Therapeutics Inc H2 2017 Alopecia-Dormant Projects H2 2017 Alopecia-Dormant Projects H2 2017 (Contd..1) H2 2017 Alopecia-Discontinued Products H2 2017
Number of Products under Development for Alopecia H2 2017 Number of Products under Development by Companies H2 2017 Number of Products under Development by Universities/Institutes H2 2017 Number of Products by Top 10 Targets H2 2017 Number of Products by Stage and Top 10 Targets H2 2017 Number of Products by Top 10 Mechanism of Actions H2 2017 Number of Products by Stage and Top 10 Mechanism of Actions H2 2017 Number of Products by Routes of Administration H2 2017 Number of Products by Stage and Routes of Administration H2 2017 Number of Products by Top 10 Molecule Types H2 2017 Number of Products by Stage and Top 10 Molecule Types H2 2017
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
